 |
|
Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study
Yong Chon Park, Shu-Yu Yang, Mian-Yoon Chong, Shigenobu Kanba, Norman Sartorius, Naotaka Shinfuku, Chay-Hoon Tan, Seon-Cheol Park
Psychiatry Investig. 2018;15(10):1007-1008. Published online 2018 Oct 22 DOI: https://doi.org/10.30773/pi.2018.09.06
|
|
QT interval prolongation noted in one percent of 2553 Asian patients with schizophrenia: Findings from the REAP‐AP survey
Seon‐Cheol Park, Bong Ju Lee, Jae Hong Park, Hiroaki Kawasaki, Ajit Avasthi, Sandeep Grover, Andi J. Tanra, Shih‐Ku Lin, Afzal Javed, Chay Hoon Tan, Norman Sartorius, Naotaka Shinfuku, Yong Chon Park
The Kaohsiung Journal of Medical Sciences.2020; 36(12): 1030. CrossRef A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study
Tomihisa Niitsu, Tatsuki Hata, Masahiko Nishimoto, Yutaka Hosoda, Atsushi Kimura, Yasunori Oda, Masatoshi Suzuki, Naoko Takase, Ryota Seki, Kiyoshi Fujita, Mitsugu Endo, Taisuke Yoshida, Masayuki Inoue, Noriaki Hattori, Tadashi Murakami, Yukitsugu Imamura
Asian Journal of Psychiatry.2020; 53: 102369. CrossRef Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
Onanong Waleekhachonloet, Chulaporn Limwattananon, Thananan Rattanachotphanit
Therapeutic Advances in Drug Safety.2019; 10: 204209861985488. CrossRef Establishing the cut-off score for aggression on the Brief Psychiatric Rating Scale-Excited Component (BPRS-EC) in schizophrenia patients
Seon-Cheol Park, Eun Young Jang, Gyung-Mee Kim, Ajit Avasthi, Sandeep Grover, Andi Jayalangkara Tanra, Takahiro A. Kato, Kok Yoon Chee, Mian-Yoon Chong, Afzal Javed, Chay Hoon Tan, Norman Sartorius, Naotaka Shinfuku, Yong Chon Park
Psychiatry and Clinical Psychopharmacology.2019; 29(4): 407. CrossRef Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia
Seon-Cheol Park, Hong Seok Oh, Adarsh Tripathi, Roy Abraham Kallivayalil, Ajit Avasthi, Sandeep Grover, Andi Jayalangkara Tanra, Shigenobu Kanba, Takahiro A. Kato, Toshiya Inada, Kok Yoon Chee, Mian-Yoon Chong, Shih-Ku Lin, Kang Sim, Yu-Tao Xiang, Chay Ho
Nordic Journal of Psychiatry.2019; 73(6): 323. CrossRef Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database
Yoko Hirano, Yoichi Ii
Clinical Drug Investigation.2019; 39(11): 1077. CrossRef The Factors Affecting the Relationship between Remission Status and Employment in Chronic Schizophrenia Patients
Burcu Rahşan Erim, Hamid Boztaş, Mustafa Yıldız, Ersin Uygun
Psychiatry Investigation.2019; 16(11): 860. CrossRef Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale: findings from the REAP-AP
Seon-Cheol Park, Eun Young Jang, Kiwon Kim, Hoseon Lee, Joonho Choi, Amitava Dan, Arshad Hussain, Andi Jayalangkara Tanra, Takahiro A. Kato, Kok Yoon Chee, Sih-Ku Lin, Chay Hoon Tan, Afzal Javed, Norman Sartorius, Naotaka Shinfuku, Yong Chon Park
Psychiatry and Clinical Psychopharmacology.2019; 29(4): 895. CrossRef
|